Zhou Weiping, Deputy President, Chief Physician, Professor. Dr. Zhou graduated from Guangzhou Medical University in 1985 and completed one year of advanced study at the Cancer Hospital of the Chinese Academy of Medical Sciences in 1990. He has participated in numerous international oncology conferences and national cancer congresses and has been involved in several national oncology collaboration groups. He has also organized and presided over multiple academic conferences on gastrointestinal tumors in Hainan Province.

He specializes in surgery-based multidisciplinary treatment integrating chemotherapy, radiotherapy, and biotherapy, as well as minimally invasive laparoscopic surgery. He was among the first in the province to perform sphincter-preserving double anastomosis surgery for low rectal cancer and laparoscopic minimally invasive surgery for gastrointestinal tumors. He has also led the development of multidisciplinary treatment (MDT) for gastrointestinal tumors and contributed to the establishment of Enhanced Recovery After Surgery (ERAS) protocols.

Scientific research: His clinical study on portal vein catheterization with 5-FU for colorectal cancer won the Fourth Prize for Scientific and Technological Advancement in Hainan Province. He has led multiple research projects funded by the Hainan Provincial Health Department and the Hainan Natural Science Foundation. He has published more than 40 papers in leading domestic and international journals. Dr. Zhou actively participates in charitable work. He was awarded "Outstanding Medical Volunteer" by the China Charity Federation in 2009 and received the "Outstanding Contribution Award" in 2017.

An expert in minimally invasive laparoscopic surgery, Dr. Zhou was among the first in the province to perform sphincter-preserving double anastomosis surgery for low rectal cancer and to apply minimally invasive radical surgery for gastrointestinal tumors. He has extensive experience in multidisciplinary treatment (MDT) for gastrointestinal cancers and in Enhanced Recovery After Surgery (ERAS) protocols.

Comprehensive diagnosis and treatment of gastrointestinal tumors.

Current Appointment:

1. Editorial Board Member of Chinese Journal of Metastatic Tumors

Previous Appointments:

1. Director of the Chinese Anti-Cancer Association

2. Committee Member of the Professional Committee on Cancer Prevention and Control of Chinese Preventive Medicine Association

3. President of the Hainan Anti-Cancer Association

4. Committee Member of the Colorectal Cancer Group of the Surgical Society of Chinese Medical Association

5. Committee Member of the Parenteral and Enteral Nutrition Professional Committee of the Chinese Research Hospital Association

6. Committee Member of the Neuroendocrine Tumor Branch of China International Exchange and Promotive Association for Medical and Health Care

1. Huang Y、 Ye M 、 Wang C、 et al. Protective effect of CDDO-imidazolide against intestinal ischemia/reperfusion injury in mice[J]. European Journal of Inflammation, 2018, 16(6):205873921880268。

2. Huang Youqun, Wang Zhenfen, Zhou Weiping. Characteristics and Clinical Significance of Changes in IL - 6, TNF - α, and CRP Levels in Colorectal Cancer Patients [J]. Cancer Progress, 2018, 16(9):3.

3. Zhou Weiping. Clinical Analysis of 38 Cases of Colorectal Cancer with Liver Metastasis [J]. Hainan Medical Journal, 2004, 15(6):2.

4. Zhou Weiping, Yang Zuoheng, Wang Guoxiong. Misdiagnosis Analysis of Rectal Cancer [J]. Hainan Medical Journal, 1995, 04:267 - 268.

5. Zhou Weiping. Experience in the Treatment of Anastomotic Leakage after Dixon Operation for Rectal Cancer [J]. Hainan Medical Journal, 1992, 003(003):41 - 42.

6. Zhou Weiping, Liu Hai, Cai Guohao, et al. Clinical Study on the Impact of 5-Fu Regional Chemotherapy on Liver Metastasis after Colorectal Cancer Surgery [J]. China Tropical Medicine, 2002, 2(2):2.

7. Zhou Weiping, Liu Hai, Fu Yong. Clinical Analysis of 110 Cases of Primary Small Intestinal Tumors [J]. China Tropical Medicine, 2003, 3(6):2.